UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Glutamate, Brain Connectivity and Duration of Untreated Psychosis

Completed

Conditions: Psychosis
Schizophrenia
Schizoaffective Disorder

Interventions: Drug: Risperidone

First Posted Date: 2014-01-13

Last Posted Date: 2019-01-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 134

Registration Number: NCT02034253

Locations: 🇺🇸
Sparks Center, Birmingham, Alabama, United States

Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease

Not Applicable

Completed

Conditions: Peripheral Arterial Disease

Interventions: Behavioral: Internet-based walking program
Behavioral: Telephone counseling

First Posted Date: 2013-12-27

Last Posted Date: 2021-12-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 172

Registration Number: NCT02022423

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States

Pressure Ulcer Healing With Microcyn

Phase 4

Completed

Conditions: Pressure Ulcer
Spinal Cord Injuries

Interventions: Drug: Microcyn
Other: Sterile saline

First Posted Date: 2013-12-05

Last Posted Date: 2018-11-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 65

Registration Number: NCT02001558

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes

Phase 1

Completed

Conditions: Type I Diabetes

Interventions: Drug: Placebo GABA and Placebo GAD-alum
Drug: GABA and Placebo GAD-alum
Drug: Active Oral GABA and Active GAD-alum injection

First Posted Date: 2013-12-05

Last Posted Date: 2022-05-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 101

Registration Number: NCT02002130

Locations: 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States

Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia

Phase 2

Completed

Conditions: Adult Lymphoblastic Lymphoma

Interventions: Drug: Fludarabine
Procedure: Total Body Irradiation

First Posted Date: 2013-11-25

Last Posted Date: 2024-01-12

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 19

Registration Number: NCT01991457

Locations: 🇺🇸
UAB Bone Marrow Transplantation and Cellular Therapy Program, Birmingham, Alabama, United States

Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease

Early Phase 1

Completed

Conditions: Anemia of Chronic Disease
Chronic Kidney Disease

Interventions: Drug: Oral Calcitriol 0.5 mcg once daily for 6 weeks
Drug: Placebo

First Posted Date: 2013-11-20

Last Posted Date: 2015-08-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT01988116

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States

Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery

Phase 1

Terminated

Conditions: Pain

Interventions: Drug: Clonidine
Drug: ropivacaine

First Posted Date: 2013-11-18

Last Posted Date: 2016-11-04

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 14

Registration Number: NCT01986751

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Vitamin D Supplementation in Older Adults With Urinary Incontinence

Not Applicable

Completed

Conditions: Urinary Incontinence
Vitamin D Deficiency

Interventions: Other: Placebo
Dietary Supplement: Vitamin D3 50,000 IU

First Posted Date: 2013-10-29

Last Posted Date: 2018-03-09

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 243

Registration Number: NCT01971801

Locations: 🇺🇸
UAB Continence Clinic at The Kirklin Clinic, Birmingham, Alabama, United States

Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis

Phase 2

Completed

Conditions: Ambulatory IPF

Interventions: Drug: Placebo
Drug: Rituximab

First Posted Date: 2013-10-25

Last Posted Date: 2024-08-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 58

Registration Number: NCT01969409

Locations: 🇺🇸
University of Minnestoa, Minneapolis, Minnesota, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States

and more 4 locations

RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke

Phase 2

Withdrawn

Conditions: Severe Stroke With Affected Arm Motor Function

Interventions: Drug: Fluoxetine
Drug: Placebo
Procedure: Usual Care
Procedure: eCMIT

First Posted Date: 2013-10-16

Last Posted Date: 2015-01-12

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT01963832

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy